Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

• Published in: Epilepsia (Copenhagen) Vol. 55; no. 6; pp. 791 - 802
• Main Authors: Devinsky, Orrin, Cilio, Maria Roberta, Cross, Helen, Fernandez‐Ruiz, Javier, French, Jacqueline, Hill, Charlotte, Katz, Russell, Di Marzo, Vincenzo, Jutras‐Aswad, Didier, Notcutt, William George, Martinez‐Orgado, Jose, Robson, Philip J., Rohrback, Brian G., Thiele, Elizabeth, Whalley, Benjamin, Friedman, Daniel
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.06.2014
• Subjects: Animals; Anticonvulsants - pharmacology; Anticonvulsants - therapeutic use; Brain - drug effects; Cannabidiol; Cannabidiol - pharmacology; Cannabidiol - therapeutic use; Cannabinoids - pharmacology; Cannabinoids - therapeutic use; Cannabis; Dravet syndrome; Drug therapy; Epilepsies, Myoclonic - drug therapy; Epilepsy; Epilepsy - drug therapy; GPR55; Humans; Intellectual Disability - drug therapy; Lennox Gastaut Syndrome; Medical marijuana; Mental Disorders - drug therapy; Phytotherapy; Plant Extracts - therapeutic use; Seizures - drug therapy; Spasms, Infantile - drug therapy; Tetrahydroacannabinol; Cannabidiol; Cannabis; Medical marijuana; Dravet syndrome; GPR55; Tetrahydroacannabinol

Summary To present a summary of current scientific evidence about the cannabinoid, cannabidiol (CBD) with regard to its relevance to epilepsy and other selected neuropsychiatric disorders. We summarize the presentations from a conference in which invited participants reviewed relevant aspects of the...